Links to 10 New Hepatitis C Abstracts in Journal of Hepatology

July 13, 2011

Predicting clinical outcomes using baseline and follow-up laboratory data from

the hepatitis C long-term treatment against cirrhosis trial

Marc G. Ghany, Hae-Young Kim, Anne Stoddard, C. , Leonard B.

Seeff and S.F. Lok, The HALT-C Trial Group

Accepted manuscript online: 11 JUL 2011 12:30PM EST | DOI: 10.1002/hep.24550

Excess liver-related morbidity of chronic hepatitis C patients, who achieve a

sustained viral response, and are discharged from care

Hamish A Innes, Sharon J Hutchinson, , Diptendu Bhattacharyya,

Bramley, Toby E S Delahooke, F Dillon, Ewan Forrest, Fraser, Ruth

Gillespie, J Goldberg, Kennedy, Mc, Allan McLeod,

R Mills, Judith and , on behalf of the Hepatitis C

Clinical Database Monitoring Committee

Accepted manuscript online: 11 JUL 2011 12:28PM EST | DOI: 10.1002/hep.24561

The antiviral protein viperin inhibits HCV replication via interaction with NS5A

Karla J. Helbig, S. Eyre, Yip, Sumudu Narayana, Kui Li,

Guillaume Fiches, M. McCartney, Rohit K. Jangra, Stanley M. Lemon and

R. Beard

Accepted manuscript online: 11 JUL 2011 12:29PM EST | DOI: 10.1002/hep.24542

The common I148 M variant of PNPLA3 does not predict fibrosis progression after

liver transplantation for hepatitis C

T. do O, Dennis Eurich, Christian Trautwein, Neuhaus, Ulf P.

Neumann and Hermann E. Wasmuth

Accepted manuscript online: 11 JUL 2011 12:30PM EST | DOI: 10.1002/hep.24535

Impact of IL28B on treatment outcome in HCV G1/4 patients receiving

response-guided therapy with peginterferon alfa-2a (40KD)/ ribavirin

-Matthias Scherzer, Albert Friedrich Stttermayer, Strasser,

Hermann Laferl, s Maieron, Rudolf Stauber, Christian Datz, Emina

Dulic-Lakovic, Petra Steindl-Munda, Harald Hofer and Ferenci

Accepted manuscript online: 11 JUL 2011 12:31PM EST | DOI: 10.1002/hep.24546

Expression of paramyxovirus V proteins promotes replication and spread of

hepatitis C virus in cultures of primary human fetal liver cells

Andrus, Svetlana Marukian, T. , Catanese,

P. Sheahan, W. Schoggins, Walter T. Barry, Lynn B. , Kartik

Trehan, Ploss, Sangeeta N. Bhatia and M. Rice

Accepted manuscript online: 11 JUL 2011 12:28PM EST | DOI: 10.1002/hep.24557

HLA-B27 selects for rare escape mutations that significantly impair hepatitis C

virus replication and require compensatory mutations

Christoph Neumann-Haefelin, Cesar Oniangue-Ndza, Kuntzen, Schmidt,

Katja Nitschke, Sidney, Célia Caillet-Saguy, Marco Binder, Nadine Kersting,

W. Kemper, A. Power, Ingber, L. Reyor, Kelsey

Hills-, Arthur Y. Kim, Georg M. Lauer, Volker Lohmann, Alessandro Sette,

R. Henn, Stéphane Bressanelli, Thimme and Todd M.

Accepted manuscript online: 11 JUL 2011 12:29PM EST | DOI: 10.1002/hep.24541

Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in

facilitating entry into hepatocytes

Budhaditya Mazumdar, Arup Banerjee, Meyer and Ranjit Ray

Accepted manuscript online: 6 JUL 2011 12:47PM EST | DOI: 10.1002/hep.24523

NK inhibitory receptor expression associated with treatment failure and IL-28B

genotype in patients with chronic hepatitis C

Lucy Golden-Mason, Kiran M. Bambha, Linling Cheng, D. Howell, Milton W.

, J. , Nezam Afdhal and Hugo R. Rosen

Accepted manuscript online: 11 JUL 2011 12:29PM EST | DOI: 10.1002/hep.24556

Retreatment with telaprevir combination therapy in hepatitis C patients with

well-characterized prior treatment response

J. Muir, Fred F. Poordad, G. McHutchison, L. Shiffman,

Berg, Ferenci, E. Heathcote, Jean-Michel Pawlotsky, Stefan

Zeuzem, Henk W. Reesink, Geoffrey Dusheiko, C. , ,

S. Kauffman and Nathalie Adda

Accepted manuscript online: 11 JUL 2011 12:30PM EST | DOI: 10.1002/hep.24549

July 13, 2011